Company intelligence / Profile preview

Syntiant

Irvine, California, United Statessyntiant.com ↗

Ownership: Private
Employees: ~202
Development stage: Other

Overview

Syntiant is a leading provider of ultra-low-power, high-performance neural processors and edge AI solutions. Its Neural Decision Processors are widely deployed in consumer, industrial, automotive, and some medical/healthcare applications for always-on audio, sensor, speech, and vision processing. The company has shipped over 50 million devices using its technology as of early 2024[7]. While not a life sciences or biotech/pharma company itself, its chips are used in healthcare-adjacent applications such as diagnostics and remote patient monitoring devices[2].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Amazon Alexa FundIntel CapitalMicrosoft M12Robert Bosch Venture CapitalAtlantic Bridge CapitalU.S. Department of Defense’s DIU

Beyond the preview

Go deeper on Syntiant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntiant.

Explore the full profile